Back to Search
Start Over
Percutaneous ethanol sclerotherapy is a promising treatment for recalcitrant angiolymphoid hyperplasia with eosinophilia.
- Source :
-
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 568-572. Date of Electronic Publication: 2021 Oct 19. - Publication Year :
- 2022
-
Abstract
- Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare benign vascular proliferation, which manifests as characteristic red nodules and papules, mostly located on the scalp and periauricular regions. Patients seek treatment for both aesthetic and functional reasons, as lesions may ulcerate, bleed and itch. Many therapeutic approaches have been reported, with variable success, and relapse remains a troublesome issue. The aim of this study was to report our experience treating ALHE using percutaneous ethanol sclerotherapy (PES). We present a retrospective case series of three patients treated with PES (1-2 treatment sessions each). All patients had tried and failed other treatments prior to this intervention, but following PES treatment, all patients demonstrated significant improvement, which was sustained at follow-up (range 8-17 months after first treatment). Adverse effects were tolerable and transient. This case series demonstrates PES as a promising treatment for recalcitrant ALHE.<br /> (© 2021 British Association of Dermatologists.)
- Subjects :
- Administration, Cutaneous
Adult
Aged
Angiolymphoid Hyperplasia with Eosinophilia pathology
Female
Humans
Retrospective Studies
Scalp Dermatoses pathology
Treatment Outcome
Angiolymphoid Hyperplasia with Eosinophilia therapy
Ethanol administration & dosage
Scalp Dermatoses therapy
Sclerotherapy methods
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2230
- Volume :
- 47
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Clinical and experimental dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 34559911
- Full Text :
- https://doi.org/10.1111/ced.14940